Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor relevant protein functional interactions identified using bipartite graph analyses. | Sci Rep | 2021 | 34728699 | PubTator, text mining | PubMed |
| Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas. | Front Genet | 2021 | 34721530 | PubTator, text mining | PubMed |
| Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis. | Biomed Res Int | 2021 | 34712733 | PubTator, text mining | PubMed |
| Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest. | Mol Ther Nucleic Acids | 2021 | 34703654 | PubTator, text mining | PubMed |
| Bioinformatics screening of biomarkers related to liver cancer. | BMC Bioinformatics | 2021 | 34696748 | PubTator, text mining | PubMed |
| Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment. | Cells | 2021 | 34685725 | PubTator, text mining | PubMed |
| Identification of Novel Endogenous Controls for qPCR Normalization in SK-BR-3 Breast Cancer Cell Line. | Genes (Basel) | 2021 | 34681026 | PubTator, text mining | PubMed |
| A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer Metastasis. | Cancers (Basel) | 2021 | 34680307 | PubTator, text mining | PubMed |
| In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer. | Cancers (Basel) | 2021 | 34680205 | PubTator, text mining | PubMed |
| UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma. | Int J Gen Med | 2021 | 34675635 | PubTator, text mining | PubMed |
| A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma. | Biomed Res Int | 2021 | 34671679 | PubTator, text mining | PubMed |
| Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond. | Front Cell Dev Biol | 2021 | 34650986 | PubTator, text mining | PubMed |
| A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma. | Front Oncol | 2021 | 34650921 | PubTator, text mining | PubMed |
| Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer. | Dis Markers | 2021 | 34646403 | PubTator, text mining | PubMed |
| Spatiotemporal coordination of the RSF1-PLK1-Aurora B cascade establishes mitotic signaling platforms. | Nat Commun | 2021 | 34635673 | PubTator, text mining | PubMed |
| CKAP2L, as an Independent Risk Factor, Closely Related to the Prognosis of Glioma. | Biomed Res Int | 2021 | 34631884 | PubTator, text mining | PubMed |
| Long Non-coding RNA Double Homeobox A Pseudogene 8: A Novel Oncogenic Propellant in Human Cancer. | Front Cell Dev Biol | 2021 | 34631702 | PubTator, text mining | PubMed |
| LncRNA RP11-499E18.1 Inhibits Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Ovarian Cancer Cells by Dissociating PAK2-SOX2 Interaction. | Front Cell Dev Biol | 2021 | 34621737 | PubTator, text mining | PubMed |
| BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. | Signal Transduct Target Ther | 2021 | 34620840 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis. | Front Genet | 2021 | 34616422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=47